Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_assertion type Assertion NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_head.
- NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_assertion description "[Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 Aug/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_provenance.
- NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_assertion evidence source_evidence_literature NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_provenance.
- NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_assertion SIO_000772 20477822 NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_provenance.
- NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_assertion wasDerivedFrom gad-20150221 NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_provenance.
- NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_assertion wasGeneratedBy ECO_0000203 NP124036.RAysXkJhA5FG8hTt-xfW-J1CSD0I-cgjNUf2q_ygflEVk130_provenance.